NewEdge Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $591 | Hold |
600
| – | – | ﹤0.01% | 3781 |
|
|
2025
Q1 | $864 | Hold |
600
| – | – | ﹤0.01% | 3650 |
|
|
2024
Q4 | $1.32K | Hold |
600
| – | – | ﹤0.01% | 3522 |
|
|
2024
Q3 | $990 | Sell |
600
-100
| -14% | -$165 | ﹤0.01% | 3510 |
|
|
2024
Q2 | $1.55K | Buy |
700
+100
| +17% | +$222 | ﹤0.01% | 3381 |
|
|
2024
Q1 | $1.61K | Hold |
600
| – | – | ﹤0.01% | 3419 |
|
|
2023
Q4 | $1.79K | Hold |
600
| – | – | ﹤0.01% | 3357 |
|
|
2023
Q3 | $588 | Hold |
600
| – | – | ﹤0.01% | 3232 |
|
|
2023
Q2 | $834 | Sell |
600
-8,222
| -93% | -$11.4K | ﹤0.01% | 3274 |
|
|
2023
Q1 | $14K | Buy |
8,822
+8,222
| +1,370% | +$13.1K | ﹤0.01% | 2460 |
|
|
2022
Q4 | $4 | Buy |
+600
| New | +$4 | ﹤0.01% | 3837 |
|